oral glp-1 for weight loss FDA UPDATE: A new medication has been approved 🚨 the first time, patients now have an FDA-approved oral option for medical management—expanding choices beyond injectable treatments. This breakthrough No injections GLP-1 Peptide Serum, Oral Solution
Description
The medication may trigger systemic inflammation, affecting the ocular surface and contributing to dry eye symptoms

The brain: quieting "food noise." GLP-1 receptors in the hypothalamus and reward centers reduce appetite and the intrusive thoughts about food that many patients with obesity describe
In her practice, McElroy has seen patients misuse everything from stimulants to laxatives as part of their illness
Shared decision-making remains central
JACC Heart

Several studies have shown that tirzepatide reduces insulin resistance, improves glycemic control, and lowers inflammatory biomarkers, including C-reactive protein and IL-6 (46, 47)
